PATIENT Act of 2023

3.0.0 775 2025-04-21T12:24:17Z 2025-04-21T12:24:17Z Senate S S 2023-03-14 118 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred To 2023-03-14T19:29:56Z PATIENT Act of 2023 118 3561 HR 2024-12-17 Referred to the Subcommittee on Health. Related bill CRS Expanding Access to Low-Cost Generics Act of 2023 118 1114 S 2023-06-22 Placed on Senate Legislative Calendar under General Orders. Calendar No. 108. Related bill CRS To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. 118 3839 HR 2023-06-09 Referred to the Subcommittee on Health. Related bill CRS Lower Costs, More Transparency Act 118 5378 HR 2023-12-11 Motion to reconsider laid on the table Agreed to without objection. 19:13:20 Related bill CRS 2023-03-14 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2023-03-14 Introduced in Senate IntroReferral 10000 9 Library of Congress H001076 Sen. Hassan, Margaret Wood [D-NH] Maggie Hassan D NH N P000603 Sen. Paul, Rand [R-KY] Rand Paul R KY 2023-03-14 True B001310 Sen. Braun, Mike [R-IN] Mike Braun R IN 2023-03-28 False H000273 Sen. Hickenlooper, John W. [D-CO] John Hickenlooper D CO W. 2023-04-25 False Health Administrative law and regulatory procedures 2023-10-11T19:30:35Z Department of Health and Human Services 2023-10-11T19:30:35Z Drug safety, medical device, and laboratory regulation 2023-10-11T19:30:35Z Prescription drugs 2023-10-11T19:30:35Z Health 2023-04-03T18:15:14Z

00 2023-03-14 Introduced in Senate 2023-10-02T19:37:32Z Increasing Transparency in Generic Drug Applications Act This bill requires the Food and Drug Administration (FDA) to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why). The FDA must also update or publish guidance on how it makes such determinations.

Increasing Transparency in Generic Drug Applications Act Display Title 45 Increasing Transparency in Generic Drug Applications Act 2024-07-24T15:23:21Z Short Title(s) as Introduced 101 Increasing Transparency in Generic Drug Applications Act 2024-05-24T13:41:41Z Introduced in Senate IS Official Title as Introduced 6 A bill to provide for increased transparency in generic drug applications. 2023-03-30T02:43:49Z Introduced in Senate IS Introduced in Senate 2023-03-14T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s775is/xml/BILLS-118s775is.xml 2023-03-14 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.